BDBM653575 3,3′-Dideoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl]-3′-[4-(2-hydroxythiazol-4-yl)-1H-1,2,3-triazol-1-yl]-1,1′-sulfanediyl-di-β-D-galactopyranoside::US20240059728, Example 1

SMILES OC[C@H]1O[C@@H](S[C@@H]2OC(CO)[C@H](O)[C@@H](C2O)n2cc(nn2)-c2cc(F)c(F)c(F)c2)[C@H](O)C(C1O)n1cc(nn1)-c1csc(O)n1

InChI Key InChIKey=HZZCZFBQVJHDMH-UHFFFAOYSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 653575   

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653575(3,3′-Dideoxy-3-[4-(3,4,5-trifluorophenyl)-1H...)
Affinity DataKd:  0.400nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653575(3,3′-Dideoxy-3-[4-(3,4,5-trifluorophenyl)-1H...)
Affinity DataKd:  3nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent